Terms: = Bone cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Diagnosis
46 results:
1. [A Case of Rectal Neuroendocrine Carcinoma with iris Metastasis].
Matsuo Y; Ichikawa Y; Sawada G; Takada A; Kim HM; Murakami M; Fukunaga H; Shirai S; Kondou S; Kimura H; Morita S
Gan To Kagaku Ryoho; 2023 May; 50(5):647-649. PubMed ID: 37218331
[TBL] [Abstract] [Full Text] [Related]
2. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Cowan A; Ferrari F; Freeman SS; Redd R; El-Khoury H; Perry J; Patel V; Kaur P; Barr H; Lee DJ; Lightbody E; Downey K; Argyelan D; Theodorakakou F; Fotiou D; Liacos CI; Kanellias N; Chavda SJ; Ainley L; Sandecká V; Pospíšilová L; Minarik J; Jungova A; Radocha J; Spicka I; Nadeem O; Yong K; Hájek R; Kastritis E; Marinac CR; Dimopoulos MA; Get G; Trippa L; Ghobrial IM
Lancet Haematol; 2023 Mar; 10(3):e203-e212. PubMed ID: 36858677
[TBL] [Abstract] [Full Text] [Related]
3. iris metastasis as resistance mechanism to atezolizumab, carboplatin, and etoposide but responds to additional irinotecan and anlotinib in a small cell lung cancer patient.
Huang Z; Zhang Y
Thorac Cancer; 2023 Mar; 14(8):779-782. PubMed ID: 36747371
[TBL] [Abstract] [Full Text] [Related]
4. Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese brca1/2-mutation carriers.
Mori T; Okamoto Y; Mu A; Ide Y; Yoshimura A; Senda N; Inagaki-Kawata Y; Kawashima M; Kitao H; Tokunaga E; Miyoshi Y; Ohsumi S; Tsugawa K; Ohta T; Katagiri T; Ohtsuru S; Koike K; Ogawa S; Toi M; Iwata H; Nakamura S; Matsuo K; Takata M
Cancer Med; 2023 Mar; 12(6):6594-6602. PubMed ID: 36345163
[TBL] [Abstract] [Full Text] [Related]
5. Trajectories of body weight change and survival among patients with mCRC treated with systemic therapy: Pooled analysis from the ARCAD database.
Franko J; Yin J; Adams RA; Zalcberg J; Fiskum J; Van Cutsem E; Goldberg RM; Hurwitz H; Bokemeyer C; Kabbinavar F; Curtis A; Meyers J; Chibaudel B; Yoshino T; de Gramont A; Shi Q;
Eur J Cancer; 2022 Oct; 174():142-152. PubMed ID: 35994794
[TBL] [Abstract] [Full Text] [Related]
6. Risk of cancer in heterozygous relatives of patients with Fanconi anemia.
McReynolds LJ; Giri N; Leathwood L; Risch MO; Carr AG; Alter BP
Genet Med; 2022 Jan; 24(1):245-250. PubMed ID: 34906449
[TBL] [Abstract] [Full Text] [Related]
7. Intraocular mass as first presenting symptom of metastatic squamous cell lung cancer.
Stenberg R; Mancini G; Guthrie T; Simon EL
Am J Emerg Med; 2021 Dec; 50():814.e1-814.e2. PubMed ID: 34275680
[TBL] [Abstract] [Full Text] [Related]
8. Pathology of breast cancer metastasis and a view of metastasis to the brain.
Sakibuzzaman M; Mahmud S; Afroze T; Fathma S; Zakia UB; Afroz S; Zafar F; Hossain M; Barua A; Akter S; Chowdhury HI; Ahsan E; Eshan SH; Fariza TT
Int J Neurosci; 2023 May; 133(5):544-554. PubMed ID: 34044732
[TBL] [Abstract] [Full Text] [Related]
9. Patients presenting with metastases: stage IV uveal melanoma, an international study.
Garg G; Finger PT; Kivelä TT; Simpson ER; Gallie BL; Saakyan S; Amiryan AG; Valskiy V; Chin KJ; Semenova E; Seregard S; Filì M; Wilson M; Haik B; Caminal JM; Catala-Mora J; Gutiérrez C; Pelayes DE; Folgar AM; Jager MJ; Doğrusöz M; Luyten GPM; Singh AD; Suzuki S;
Br J Ophthalmol; 2022 Apr; 106(4):510-517. PubMed ID: 33452185
[TBL] [Abstract] [Full Text] [Related]
10. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of a web-based calculator to predict individualized conditional risk of site-specific recurrence in nasopharyngeal carcinoma: Analysis of 10,058 endemic cases.
Wu CF; Lv JW; Lin L; Mao YP; Deng B; Zheng WH; Wen DW; Chen Y; Kou J; Chen FP; Yang XL; Zheng ZQ; Li ZX; Xu SS; Ma J; Sun Y
Cancer Commun (Lond); 2021 Jan; 41(1):37-50. PubMed ID: 33270990
[TBL] [Abstract] [Full Text] [Related]
12. Development and external validation of nomograms to predict sarcoma-specific death and disease progression after surgical resection of localized high-grade conventional primary central chondrosarcoma and dedifferentiated chondrosarcoma.
Tsuda Y; Tsoi K; Stevenson JD; Laitinen M; Ferguson PC; Wunder JS; Griffin AM; van de Sande MAJ; van Praag V; Leithner A; Fujiwara T; Yasunaga H; Matsui H; Parry MC; Jeys LM
Bone Joint J; 2020 Dec; 102-B(12):1752-1759. PubMed ID: 33249892
[TBL] [Abstract] [Full Text] [Related]
13. Biallelic variants in
Chirita-Emandi A; Andreescu N; Popa C; Mihailescu A; Riza AL; Plesea R; Ioana M; Arghirescu S; Puiu M
J Med Genet; 2021 Sep; 58(9):648-652. PubMed ID: 32843487
[TBL] [Abstract] [Full Text] [Related]
14. Tumor protein expression of the DNA repair gene brca1 and lethal prostate cancer.
Stopsack KH; Gerke T; Zareba P; Pettersson A; Chowdhury D; Ebot EM; Flavin R; Finn S; Kantoff PW; Stampfer MJ; Loda M; Fiorentino M; Mucci LA
Carcinogenesis; 2020 Jul; 41(7):904-908. PubMed ID: 32556091
[TBL] [Abstract] [Full Text] [Related]
15. [Genetic analysis of Japanese patients with Fanconi anemia: novel findings].
Mori M; Yabe H; Yabe M; Takata M
Rinsho Ketsueki; 2019; 60(6):691-701. PubMed ID: 31281162
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant regulation of RANKL/OPG in women at high risk of developing breast cancer.
Kiechl S; Schramek D; Widschwendter M; Fourkala EO; Zaikin A; Jones A; Jaeger B; Rack B; Janni W; Scholz C; Willeit J; Weger S; Mayr A; Teschendorff A; Rosenthal A; Fraser L; Philpott S; Dubeau L; Keshtgar M; Roylance R; Jacobs IJ; Menon U; Schett G; Penninger JM
Oncotarget; 2017 Jan; 8(3):3811-3825. PubMed ID: 28002811
[TBL] [Abstract] [Full Text] [Related]
17. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of expression profiles of microRNAs and two target genes, FOXO3a and RUNX2, effectively supports diagnostics and therapy predictions in breast cancer.
Jurkovicova D; Magyerkova M; Sestakova Z; Copakova L; Bella V; Konecny M; Krivjanska M; Kulcsar L; Chovanec M
Neoplasma; 2016; 63(6):941-951. PubMed ID: 27596294
[TBL] [Abstract] [Full Text] [Related]
19. Building capacity for human genetics and genomics research in Trinidad and Tobago.
Roach A; Warner WA; Llanos AA
Rev Panam Salud Publica; 2015 Nov; 38(5):425-30. PubMed ID: 26837529
[TBL] [Abstract] [Full Text] [Related]
20. Osteoporosis risk and management in brca1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.
Garcia C; Lyon L; Conell C; Littell RD; Powell CB
Gynecol Oncol; 2015 Sep; 138(3):723-6. PubMed ID: 26086567
[TBL] [Abstract] [Full Text] [Related]
[Next]